• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Vertex Pharmaceuticals (NQ: VRTX )

    482.01 +0.77 (+0.16%)
    Streaming Delayed Price Updated: 11:31 AM EDT, Aug 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 199,255
    Open 481.98
    Bid (Size) 481.77 (4)
    Ask (Size) 482.30 (2)
    Prev. Close 481.24
    Today's Range 481.46 - 485.00
    52wk Range 340.83 - 510.63
    Shares Outstanding 259,428,394
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
    Via Benzinga
    Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead
    Vertex Pharmaceuticals has a lot going for it. 
    Via The Motley Fool

    Performance

    YTD
    +17.30%
    +17.30%
    1 Month
    -2.68%
    -2.68%
    3 Month
    +7.86%
    +7.86%
    6 Month
    +11.20%
    +11.20%
    1 Year
    +37.09%
    +37.09%

    More News

    Read More
    Vertex to Participate in Upcoming September Investor Conferences
    From Vertex Pharmaceuticals Incorporated
    Via Business Wire
    If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,900 Today
    Via Benzinga
    Biotech Bull Market: 3 Ways To Play It
    Via Talk Markets
    Topics Economy
    Exposures Interest Rates
    Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
    Via Benzinga
    Soviet Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings
    Via Benzinga
    These 2 Incredible Growth Stocks Are Set to Soar This Summer and Beyond
    Via The Motley Fool
    3 Fantastic Growth Stocks to Buy in August
    Via The Motley Fool
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    3 Biotech Stocks to Buy on the Dip: August 2024
    Via InvestorPlace
    Prediction: These 4 Future Technologies Will Be Millionaire-Makers -- and Here Are the Top Stocks to Buy Now to Profit From Them
    Via The Motley Fool
    2 Biotech Stocks to Buy Hand Over Fist in August
    Via The Motley Fool
    The 3 Best Biotech Stocks to Buy in August 2024
    Via InvestorPlace
    Vertex Announces CASGEVY™ Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in England
    From Vertex Pharmaceuticals
    Via Business Wire
    Is It Too Late to Buy Vertex Pharmaceuticals Stock?
    Via The Motley Fool
    Prediction: These Could Be the Best-Performing Growth Stocks Through 2030
    Via The Motley Fool
    3 Biotech Stocks on Track for 50% Returns (or More) by 2028
    Via InvestorPlace
    Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker
    Via The Motley Fool
    3 Unstoppable Stocks to Buy in August
    Via The Motley Fool
    Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now
    Via The Motley Fool
    3 Biotech Stocks That Could Have Investors Grinning Soon
    Via InvestorPlace
    Magnificent 7 Lose Over $300B As Volatility Index Surges, Traders Question Fed's Timing: What's Driving Markets Friday?
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Vertex Pharmaceuticals Lifts Annual Guidance, Positive Growth For Its Cystic Fibrosis Franchise And Pain Management Pipeline
    Via Benzinga
    Should Investors Worry About Vertex Pharmaceuticals $3.6 Billion Q2 Loss? Not Even for a Second.
    Via The Motley Fool
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.